Open AccessCOVID-19 vaccines: Keeping pace with SARS-CoV-2 variants
Author(s) -
Müge Çevik,
Nathan D. Grubaugh,
Akiko Iwasaki,
Peter Openshaw
Publication year - 2021
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2021.09.010
Subject(s) - biology , virology , covid-19 , betacoronavirus , coronavirus infections , sars virus , outbreak , infectious disease (medical specialty) , disease , pathology , medicine
As the SARS-CoV-2 pandemic evolves, new variants continue to emerge. Some highly transmissible variants, such as Delta, also raised concerns about the effectiveness provided by current vaccines. Understanding immunological correlates of protection and how laboratory findings correspond to clinical effectiveness is imperative to shape future vaccination strategies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom